We talk a lot about privacy and how we can and cannot reach the public about clinical trials. What is privacy? By definition, privacy is “the quality or state of being apart from company or observation; seclusion or freedom from unauthorized intrusion.” So what does…
By Dan McDonald Multinational clinical trials are challenging. The international industry is rapidly maturing, but horror stories are still common: “Our study drug is melting in a hot locker in customs, and I can’t get hold of anyone.” “Sure, that country enrolled like gangbusters, but…
As 2013 rapidly comes to a close, we reflect back, analyze and establish forward 2014 goals for our organization. Reflecting back provides us with more awareness of trends affecting all of us in the life-sciences industry. Consolidation and outsourcing have continued, as has increased awareness…
Do you ever feel there isn’t enough time in the day to get everything done? In the life-science industry, we are forever trying to achieve completion in time for the next site initiation visit or first patient in. Ensuring clinical trial materials are on-site in time can be…
The emergence of personalized medicine adds new complexity to patient recruitment, as clinical trial sponsors require participants to meet more granular criteria, including ethnicity. The challenge for drug development companies is to craft recruitment campaigns that educate, resonate and inspire communities of color to become…